Multi-Manager Framework: Greenwald + Dalio + Soros + Druckenmiller + Laffont + Ackman + Cohen/Griffin
Generated: 2026-07-21 03:59:12 · EDGAR + yfinance
TNXXF trades at 31% discount to EPV, the market is pricing this as if current earnings power doesn't exist. Grade A quality with 27.1% owner earnings yield. This is a Greenwald deep value setup where you're buying the balance sheet and getting the business for free.
Neutral setup, no strong reflexivity signal. Limited catalysts visible. Monitor for Stage 2 entry signal. Patience is a position.
| Ticker | Rationale | Mkt Cap | EV/EBITDA TTM | EV/EBIT TTM | EV/Rev TTM | EV/FCF TTM | Fwd P/E FWD | EBITDA Mg TTM | Rev Gr. YoY | ND/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|
| PGR ✓ | Primary: Progressive, P&C insurance; best com | $123B | 24.1x | N/A | 2.0x | 11.7x | 13.1x | +8% | +16% | 0.5x |
| ALL ✓ | Primary: Allstate, personal lines P&C; scale | $65B | 11.1x | N/A | 1.3x | 13.1x | 9.6x | +11% | +8% | 1.1x |
| TRV ✓ | Primary: Travelers, commercial P&C; diversifi | $81B | 15.6x | N/A | 2.2x | N/A | 12.5x | +14% | +9% | 1.1x |
| MET ✓ | Adjacent: MetLife, life + group benefits; dif | $60B | 18.0x | N/A | 1.6x | N/A | 8.4x | +9% | +3% | 2.4x |
| AIG ✓ | Adjacent: American International, global P&C; | $42B | N/A | N/A | 1.6x | 11.8x | 9.0x | N/A | -15% | N/A |
| Peer Median | N/A | 16.8x | N/A | 1.6x | 11.8x | 9.6x | +10% | N/A | 1.1x | |
| Subject Company | N/A | 3.0x | N/A | 0.6x | 3.1x | N/A | +19% | N/A | -0.6x | |
| Base EBIT (Operating Income) TTM | $3.2B |
| Adjusted EBIT | $3.2B |
| × (1 − Tax Rate) (23.4% actual ETR) | $2.5B |
| Sustainable NOPAT ÷ WACC (6.4%) | $38.8B |
|
Santos/Greenwald Enhancements
ROIC 30.2% (Franchise)
| |
| 1 | Base EBIT (Operating Income) | $3.2B | From income statement |
| 2 | = Adjusted EBIT | $3.2B | |
| 3 | x (1 - Tax Rate) | 23.4% actual ETR | |
| = | Sustainable NOPAT | $2.5B | Net Operating Profit After Tax |
| / | WACC (6.4%) | Weighted average cost of capital | |
| = | EPV Operating | $38.8B | Enterprise value on no-growth basis |
| + | Cash | +$5.3B | |
| - | Total Debt | -$0 | |
| = | EPV of Equity | $44.1B | |
| / | Shares Outstanding | 258M | |
| = | EPV Per Share | $170.62 | vs. Market Price $116.87 |
| Ticker | Rationale | Mkt Cap | EV/EBITDA TTM | EV/EBIT TTM | EV/Rev TTM | EV/FCF TTM | Fwd P/E FWD | EBITDA Mg TTM | Rev Gr. YoY | ND/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|
| PGR ✓ | Primary: Progressive, P&C insurance; best com | $123B | 24.1x | N/A | 2.0x | 11.7x | 13.1x | +8% | +16% | 0.5x |
| ALL ✓ | Primary: Allstate, personal lines P&C; scale | $65B | 11.1x | N/A | 1.3x | 13.1x | 9.6x | +11% | +8% | 1.1x |
| TRV ✓ | Primary: Travelers, commercial P&C; diversifi | $81B | 15.6x | N/A | 2.2x | N/A | 12.5x | +14% | +9% | 1.1x |
| MET ✓ | Adjacent: MetLife, life + group benefits; dif | $60B | 18.0x | N/A | 1.6x | N/A | 8.4x | +9% | +3% | 2.4x |
| AIG ✓ | Adjacent: American International, global P&C; | $42B | N/A | N/A | 1.6x | 11.8x | 9.0x | N/A | -15% | N/A |
| Peer Median | N/A | 16.8x | N/A | 1.6x | 11.8x | 9.6x | +10% | N/A | 1.1x | |
| Subject Company | N/A | 3.0x | N/A | 0.6x | 3.1x | N/A | +19% | N/A | -0.6x | |
| Asset | Book | Haircut | Liquidation |
|---|---|---|---|
| Cash | $5.7B | 100% | $5.7B |
| Receivables | $68.8B | 85% | $58.5B |
| Inventory | $68.8B | 60% | $41.3B |
| PP&E | $877.0M | 50% | $438.5M |
| Other | $34.4B | 25% | $8.6B |
| Goodwill | $1.6B | 0% | N/A |
| Intangibles | $668.0M | 0% | N/A |